PATIENT ACCESS TO HIGH-RISK DEVICES FOR UNMET MEDICAL NEEDS

Patients with unmet medical needs face significant challenges in accessing high-risk medical devices, such aspacemakers, artificial organs, and neurostimulators, which are vital for treating severe conditions that standardtherapies cannot address. Despite their life-sustaining and life-enhancing potential, these devices are often hinderedby regulatory delays, high costs, limited insurance coverage, and ethical concerns. This article explores the complexrelationship between ensuring patient safety and facilitating timely access to high-risk medical devices. It examinesregulatory frameworks, such as the FDA's Breakthrough Devices Program and the Humanitarian Device Exemption,which aim to expedite device approval but often remain limited in scope. Additionally, the financial challenges andlogistical barriers faced by healthcare providers in delivering these devices are discussed. The article proposes severalstrategic solutions, including policy reforms to streamline approval processes, the use of post-market surveillancetechnologies to ensure safety, and improved collaboration between regulatory bodies, manufacturers, and healthcareprofessionals. Public-private partnerships and patient advocacy groups play a crucial role in bridging these gaps andcreating a healthcare system that better meets patient needs. By combining innovative strategies and addressing accessbarriers, a more equitable healthcare ecosystem can be developed, ensuring that patients in urgent need of high-riskmedical devices receive timely, safe, and effective care. Ultimately, the article calls for a patient-centered regulatoryapproach that drives progress, enhances quality of life, and contributes to longer, healthier lives